Antiplatelet agent vs control
Fatal or nonfatal stroke · people with chronic kidney disease (predialysis (GFR 15 to 60 mL/min/1.73 m²), HD, PD, transplant recipients)
It is very uncertain whether antiplatelet agents changes fatal or nonfatal stroke compared with control (very low certainty).
1 finding from 1 review
- RR 1.01 [0.64, 1.59]12 studies · 10382 participantsVery low